Bringing new treatment option to patients.
The third biosimilar of Avastin® to enter the market in China
The results showed that the novel GalNAc moieties are more convenient and affordable.Compared with the traditi...
The research demonstrates that LY-CovMab exhibits excellent neutralization potency against pseudovirus and aut...
Brings Increased Clinical Benefits to Schizophrenia Patients through World-leading Microsphere Technology
Comprehensively Improving Symptoms of Depression with Triple Reuptake Inhibitor Profile
TOP